Abstract Colony-stimulating factor 1 receptor (CSF1R) is expressed in monocytes/macrophages and dendritic cells. These cells play important roles in the innate immune response, which is regarded as an important aspect of asthma development. Genetic alterations in the CSF1R gene may contribute to the development of asthma. We investigated whether CSF1R gene polymorphisms were associated with the risk of asthma. Through direct DNA sequencing of the CSF1R gene, we identiWed 28 single nucleotide polymorphisms (SNPs) and genotyped them in 303 normal controls and 498 asthmatic patients. Expression of CSF1R protein and mRNA were measured on CD14-positive monocytes and neutrophils in peripheral blood of asthmatic patients using Xow cytometry and real-time PCR. Among the 28 polymorphisms, two intronic polymorphism (+20511C>T and +22693T>C) were associated with the risk of asthma by logistic regression analysis. The frequencies of the minor allele at CSF1R +20511C>T and +22693T>C were higher in asthmatic subjects than in normal controls (4.6 vs. 7.7%, p = 0.001 in co-dominant and dominant models; 16.4 vs. 25.8%, p = 0.0006 in a recessive model). CSF1R mRNA levels in neutrophils of the asthmatic patients having the +22693CC allele were higher than in those having the +22693TT allele (p = 0.026). Asthmatic patients with the +22693CC allele also showed signiWcantly higher CSF1R expression on CD14-positive monocytes and neutrophils than did those with the +22693TT allele (p = 0.045 and p = 0.044). The +20511C> T SNP had no association with CSF1R mRNA or protein expression. In conclusion, the minor allele at CSF1R +22693T>C may have a susceptibility eVect in the E. K. Shin and S.-H. Lee contributed equally as the Wrst author.
development of asthma, via increased CSF1R protein and mRNA expression in inXammatory cells.
Introduction
Asthma and its phenotypes are complex traits induced by interactions between the surrounding environment and multiple disease susceptibility genetic factors (Sengler et al. 2002) . Allergic asthma has been recognized as an antigendependent T-helper type 2 (Th2)-related disease with a cytokine response proWle that includes interleukin (IL)-4, IL-5, and IL-13. These cytokines play important roles in the coordination and persistence of the airway inXammatory process in allergic asthma (Cohn et al. 2004) .
Recently, the innate, non-antigen-dependent immune system has received as much attention in the pathogenesis of asthma as an antigen-dependent adaptive immune response because adaptive immune responses are dependent on activation of the innate system (Kanzler et al. 2007 ). Many innate immune receptors, such as the Toll-like receptors (TLR), NOD proteins, Dectin, CD14, and collectins, have been discovered (Beutler 2004) . TLR2 is associated with increased allergic inXammation and airway hyper-reactivity in a murine allergic model (Redecke et al. 2004) , whereas TLR4 ligands can decrease allergic responses (Velasco et al. 2005) . In these processes, dendritic cells (DCs) play a central role in initiating and regulating the adaptive and innate immune responses (Iwasaki and Medzhitov 2004) .
Colony-stimulating factor 1 (CSF1, also referred to as macrophage CSF or M-CSF) has been found to be an essential factor for the growth, survival, and diVerentiation of monocyte/macrophages (Stanley et al. 1997) . Furthermore, CSF1 has important roles in DC diVerentiation and function. CSF1 upregulates human monocyte expression of the P2X7 extracellular ATP receptor (Zhang et al. 2005) , which regulates DCs and macrophage inXammatory function, favoring the generation of cytokines that stimulate T helper 2 responses (la Sala et al. 2003) .
CSF1 acts via speciWc binding to its high-aYnity receptor CSF1R (CD115 antigen), encoded by the c-fms protooncogene. Upon binding, CSF1 induces CSF1R tyrosine phosphorylation, leading to the activation of Ras-ERK and PI3K and to the formation of DNA-binding complexes containing STAT-1, STAT-3, and STAT-5 (Hamilton 1997) . The human CSF1R gene is located on chromosome 5q33-q35. Whole-genome analyses have shown that chromosome region 5q33-q35 contains a gene cluster of ADRB2 and IL17RB receptors, key molecules contributing to the development of asthma and atopy in several ethnic populations (Holberg et al. 2001; Ober et al. 1998; Xu et al. 2001; Yokouchi et al. 2000) . Considering these biological eVects of CSF1R and its linkage to chromosome 5q33-q35, genetic variants of CSF1R may be involved in asthma. However, no report has examined its association with asthma development. In an eVort to discover polymorphism(s) in the CSF1R gene that may have eVects in asthma and related phenotypes, we identiWed 28 SNPs of the CSF1R gene and genotyped them in 498 asthmatic patients and 306 normal controls.
Materials and methods

Subjects
Subjects were recruited from the Genome Research Center for Allergy and Respiratory Diseases at Soonchunhyang University, Bucheon, Seoul, and Chunan Hospital, Korea. All patients were diagnosed by a physician and met the deWnition of asthma in the Global Initiative for Asthma (GINA) guidelines (Bateman et al. 2008) . All patients had a history of dyspnea and wheezing during the previous 12 months, plus one of the following: (1) >15% increase in FEV 1 or >12% increase plus 200 mL following inhalation of a short-acting bronchodilator, (2) <10 mg/mL PC20 methacholine, and (3) >20% increase in FEV 1 following 2 weeks of treatment with systemic or inhaled steroids and long-acting bronchodilators. The normal subjects were recruited from the patients' spouses and members of the general population who had no respiratory symptoms and had an FEV 1 > 75% of the predicted value, PC20 methacholine >10 mg/mL, and normal Wndings on a plain chest X-ray. Twenty-four common inhalant allergens [e.g., dust mites (Dermatophagoides farinae and D. pteronyssinus), aspergillus, cat fur, dog fur, cockroaches, grasses, trees, and ragweed pollens] were used for a skin prick test. Atopy was deWned as having a wheal reaction greater than or equal to histamine or 3 mm in diameter. Total IgE was measured using the Fluoroenzymeimmunoassay (Phadia AB, Uppsala, Sweden). Written informed consent was obtained from all subjects. Study protocols were approved by the Institutional Review Board of Soonchunhyang University Hospital.
Sequence analysis of human CSF1R
We sequenced CSF1R gene, including a promoter region (1.5 kb), to discover single nucleotide polymorphisms (SNPs) in DNA samples from 24 Koreans using the BigDye Terminator (v3.1) Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and an ABI PRISM 3700 DNA analyzer (Applied Biosystems). The primer sets used for ampliWcation and sequencing were designed based on sequence information from GenBank (Ref. (Fig. 1b) . These included three SNPs in the promoter (¡27162C>T, ¡27068C>G, and ¡27022C>T), 21 SNPs in introns (¡26465G>A, ¡26306G>A, +5815C>T, +6610A>G, +849 8T>C, +9180C>T, +9219A>T, +11680G>T, +13198G>A, +14665G>A, +15629G>A, +18363C>T, +20511C>T, +21997C>T, +22693T>C, +23443G>A, +25268C>T, +25995C>G, +28801C>G, +29446G>A, and +30473C>A), three SNPs in exons (+5648C>T, +8313C>T, and +15859A>G), and one SNP in the 3Ј-UTR (+33128A>G). The SNPs were genotyped at a multiplex level using Illumina's Golden Gate genotyping system (Oliphant et al. 2002) , and data quality was assessed using duplicate DNA (n = 10). The genotype quality score for keeping data was set to 0.25. SNPs that could not satisfy the following criteria were excluded: (1) a minimum call rate of 90%, (2) no duplicate error, and (3) Hardy-Weinberg equilibrium greater than p > 0.001. Twenty-eight SNPs were successfully genotyped. Information about the primers is provided in Supplementary Table 1. Measurement of CSF1R protein expression on CD14-positive monocytes and neutrophils of asthmatic patients Neutrophils and mononuclear cells (PBMC) were puriWed from the heparinized peripheral blood of asthmatic patients using a Percoll gradient (1.115, 1.100, 1.090, and 1.070). Mouse anti-human M-CSF R mAb (R&D Systems, Minneapolis, USA) was incubated with 5 £ 10 5 PBMC or neutrophils, followed by treatment with 50 g of PE-conjugated goat anti-mouse IgG (BD Biosciences, San Jose, CA, USA) for CSF1R staining. Additionally, PBMC was incubated with FITC-conjugated mouse anti-human CD14 (BD Biosciences). Stained cells were analyzed using a Xow cytometer (FACScan, Becton-Dickinson, Mountain View, CA, USA). For isotype-matched controls, PE-conjugated mouse IgG1 (R&D Systems) and FITC-conjugated mouse IgG2a kappa (BD Biosciences) were used, with the same concentration of each antibody tested.
RNA extraction and real-time PCR of CSF1R m-RNA Total RNA was isolated from neutrophils using a modiWed guanidium thiocyanate-phenol-chloroform extraction method (Schreiber et al. 1989) . We quantiWed RNA and reverse transcribed cDNA from 3 g of total RNA. DNase I (10,000 U/mL; Stratagene, La Jolla, CA, USA)-treated RNA was reverse-transcribed by incubating with 0.5 mM dNTP, 2.5 mM MgCl 2 , 5 mM DTT, 1 L of random hexamer (50 g/ L), and SuperScript II RT (200 unit/ L, Life Technologies, Grand Island, NY, USA) at 42°C for 50 min, and heat-inactivated at 70°C for 15 min.
SpeciWc primer pairs for RT-PCR were as follows: -actin forward: 5Ј-GGACTTCGAGCAAGAGATGG-3Ј; -actin reverse: 5Ј-AGCACTGTGTTGGCGTACAG-3Ј and CSF1R forward: 5Ј-CACCTTCACCCTCTCTCTGC-3Ј; CSF1R reverse: 5Ј-AGCATCTTCACAGCCACCTT-3Ј. AmpliWcation was performed for 30 cycles (one cycle: 30 s at 94°C, 30 s at 55°C, and 40 s at 72°C) with initial denaturation at 94°C for 5 min and a Wnal extension at 72°C for 10 min. The size and amount of the PCR products generated were determined by agarose gel electrophoresis in the presence of ethidium bromide and analyzed with the Kodak EDAS 1D analysis package. The cDNA fragment of the CSF1R gene contained from exon10 to exon12. cDNA was aliquoted into tubes containing speciWc primer pairs for human PGK1 (phospho glyc er ate kinase1), human -actin, and CSF1R genes for ampliWcation (191, 233 , and 263 bp fragments, respectively) using RT-PCR. Nucleotide sequences of the primers were as fol lows: PGK1 forward: 5Ј-CCTGGGCGG AGCTAAAGTTG-3Ј; PGK1 reverse: 5Ј-T CTCAGCTTTGG ACATTAGGTCT-3Ј; -actin forward: 5Ј-GGACTTCGA GCAAGAGATGG-3Ј; -actin reverse: 5Ј-AGCACTGTGT TGGCGTACAG-3Ј; CSF1R forward: 5Ј-CAGAGCCT GCTGACTGTTGA-3Ј; CSF1R reverse: 5Ј-TTGCCCTCATA GCTCTCGAT-3. The primers of PGK1 and -actin were prepared using the Primerbank web server (http://pga. mgh.harvard.edu/primerbank/). RT-PCR was performed with the StepOne™ Real-Time PCR System (Applied Biosystems, CA, USA). The reactions were prepared with 20 L PCR mixture consisting of 10 L master mix (iQ SYBR Green Supermix; Bio-Rad, Hercules, CA, USA), 1 g/ L cDNA template, and 1 L each of the CSF1R primer pair. Reactions were denatured at 95°C for 10 min and ampliWed for 40 cycles at 95°C for 15 s, 57°C for 32 s, and 72°C for 30 s. A melting curve for all products was obtained immediately after ampliWcation by increasing temperature in 0.3°C increments from 60°C for 85 cycles of 15 s each. The threshold cycle (Ct) of CSF1R or endogenous reference gene was deWned as the fractional cycle number at which the Xuorescence of PCR products passed the Wxed threshold. Using the 2 ¡ Ct method, the data are presented as the fold change in gene expression, normalized to an endogenous reference gene (PGK1 and -actin) and relative to a control (+22693 TT and +22693 CC genotype of CSF1R). For the control sample, Ct equals zero and 2 0 = 1, so that the fold change in gene expression relative to the control = 1, by deWnition (Livak and Schmittgen 2001) . For the other samples, evaluation of 2 ¡ Ct indicates the fold change in gene expression relative to the control. Fold diVerences in CSF1R mRNA expression in each patient were also calculated by comparing 2 ¡ Ct .
Statistical analyses
Linkage disequilibria (LD) between loci were measured as Lewontin's DЈ (|DЈ|) and r 2 . Haplotypes of each individual were inferred using the algorithm (PHASE, version 2.0), developed by Stephens et al. (2001) . The associations of Hap.
Freq.
Hap.
Haplotypes in CSF1R
T
C A C C T A G A A G A T C T T G T C C A C A 0.028 ht10 C T A C T C A G A A G G C C C T G T C C A C A 0.023 ht11 T C A C T C A G A A G G C C T T G T C C A C A 0.020 ht12 C T A C T C A G A A A G C C C C A C C C G A G 0.018 ht13 T C A C C T A G G G G A C C T T A C G C G C G 0.018 ht14 C T A C T C A G A A G G C C T T A C G C G C G 0.016 ht15 C T A C T C A G A A G G C C C C G C G G G C A 0.016 ht16 C C A C T C A T G G G A T T T T G T C C A C A 0.016 ht17 T C A C C T A G G G G A C C C C A C C C G C A 0.013 ht18 C T A C T C A T G G G A T T C C G C G G G C A 0.010 ht19 C T A C C C A T G G G A T T C C G C G G G C A 0.010 ht20 C C A C T C A T G G G A T T C C G T G G G C A 0.010
CSF1R genotypes and haplotypes with the risk of asthma were analyzed by logistic analysis, controlling for age (continuous value), gender (male = 0, female = 1), smoking status (non-smoker = 0, ex-smoker = 1, smoker = 2) and atopy status (non-atopy = 0, atopy = 1) as co-variables. Statistical analyses were performed using the SAS (v9.1; SAS Institute, Cary, NC, USA) and SPSS software (v11; SPSS, Inc., Chicago, IL, USA). p values of <0.05 were deemed to indicate statistical signiWcance. The eVective number of independent marker loci in CSF1R was calculated to correct for multiple testing using SNPSpD (http://genepi.qimr.edu.au/ general/daleN/SNPSpD/) based on the spectral decomposition (SpD) of matrices of pair-wise LD between SNPs (Nyholt 2004) . The number of independent marker loci in CSF1R was calculated as 4.5008 and 20.0301 in CSF1R-ht-block1 and CSF1R-ht-block2. The Wnal number of independent marker loci in CSF1R was 24.531. In vitro analysis, diVerences between independent groups and samples were evaluated using a non-parametric Kruskal-Wallis H test for continuous data. When signiWcant diVerences were found, a Mann-Whitney U test was performed to detect diVerences between pairs of samples. Statistical signiWcance was deWned as p < 0.05.
Results
Characteristics of the study subjects
The clinical characteristics of the study subjects are summarized in Table 1 . SigniWcant diVerences were found in mean age and prevalence of smoking between the normal controls and asthmatic patients (p = 0.001). FVC, FEV 1 , and PC20 values were signiWcantly lower in the asthmatic subjects than in the normal controls (p < 0.001). IgE level, atopy prevalence, and eosinophil number were signiWcantly higher in the asthmatic patients (p < 0.001).
Association of SNPs in CSF1R with asthma risk
Pair-wise comparisons of the SNPs revealed two sets of absolute LDs (|DЈ| = 1 and r 2 = 1: ¡27068C>G, ¡27022C> T; +13198G>A, +14665G>A); several complete LDs (|DЈ| = 1 and r 2 1) were also found (Fig. 1d) . Haplotypes of CSF1R were constructed using the PHASE software, and eight major haplotypes with over 5% of MAF were used for (Fig. 1c) . The genotype distributions of the 28 SNPs were in Hardy-Weinberg equilibrium for all subjects (p > 0.05, Supplementary Table 2 ). The frequency of each of the 28 polymorphisms and eight haplotypes was compared between the asthmatic participants and normal controls using logistic regression. The allele frequencies in the asthmatic and normal control subjects are shown in Supplemental Table 3 , and the p values of each SNP are shown in Fig. 1a . Among the 28 polymorphisms tested, two intronic polymorphisms (+20511C>T and +22693T>C) were associated with asthma risk (Fig. 1a ; Table 2 ; p = 0.001 in co-dominant and dominant models and p = 0.0006 in a recessive model). After correcting for multiple comparisons, the diVerence remained signiWcant in the two CSF1R SNPs (p = 0.02 and 0.01, respectively). Frequencies of the T alleles at CSF1R +20511C>T in the asthmatic group were higher than in the normal control group (49.5 vs. 36.7%, OR = 1.55, p = 0.001). In the analysis of the recessive model, the frequency of the C allele at CSF1R +22693T>C in the asthmatic group was higher than in the normal control group (25.8 vs. 16.4%, OR = 1.99, p = 0.0006). The data suggest that the T alleles at CSF1R +20511C>T and the C allele at CSF1R +22693T>C have a genetic susceptibility eVect on the development of asthma.
Flow cytometric analysis for CSF1R protein expression on peripheral blood CD14-positive monocytes and neutrophils from asthmatic subjects
The CSF1R expression was measured on peripheral blood neutrophils and CD14-positive monocytes obtained from asthmatic patients by Xow cytometry (Fig. 2) . The CD14 + monocytes from asthmatic patients with the C alleles at +22693T>C showed signiWcantly higher CSF1R expression than those with the TT alleles at +22693T>C (46.33 § 4.62 vs. 83.52 § 12.64, p = 0.045; Fig. 2e ). The expression showed a similar trend in neutrophils. The level of CSF1R expression was signiWcantly increased on neutrophils having the +22693 CC alleles versus those having +22693 T alleles (2.42 § 0.3 vs. 5.62 § 1.75, p = 0.044; Fig. 2f ). In contrast, CSF1R expression was not diVerent according to the genotypes of CSF1R +20511C>T (data not shown).
Comparison of CSF1R mRNA levels from its SNP subtypes
To investigate the genetic eVect of the +22693 T>C polymorphism on mRNA expression of the CSF1R gene in neutrophils, CSF1R mRNA levels were measured. Because CSF1R +22693 T>C is located in intron 11, we ampliWed mRNA containing the CSF1R gene using primers to detect Table 2 Genotype distribution of CSF1R polymorphisms in asthmatics (BA) and normal subjects (NC) of the study subjects * Controlled for age (continuous value), sex (male = 0, female = 1), atopy status (non-atopy = 0, atopy = 1), and smoking status (non-smoker = 0, ex-smoker = 1, smoker = 2) as co-variables. The eVective number of independent marker loci in CSF1R was calculated to correct for multiple testing, using the software SNPSpD (http://genepi.qimr.edu.au/general/daleN/SNPSpD) (Nyholt 2004 ). The number of independent marker loci in CSF1R was calculated as 4.5008 and 20.0301 in ht-block1 and ht-block2 alternative splicing, as described in "Materials and methods" and Fig. 3a . To identify the RT-PCR products, sequences were examined using the BLAST search program after direct sequencing. The ampliWed RT-PCR fragment from exon 8 to exon 13 was 758 bp in length (Fig. 3b) and that of the RT-PCR product from exon 10 to exon 12 was 263 bp. Both of them shared 100% sequence identity with the human CSF1R gene. In the RT-PCR products, no alternative splicing was found in the common or rare homozygotes of +22693 T>C (Fig. 3b) . Quantitation of mRNA expression in neutrophils from 12 asthmatics was performed by determining the concentration of the CSF1R RT-PCR products, corrected by that of -actin and PGK1 (Fig. 3c) . The expression level of total CSF1R mRNA in neutrophils was higher in patients having +22693 T alleles versus those having +22693 C alleles (Fig. 3d ).
Discussion
In this study, we identiWed 28 genetic variants in the exons, introns, and Xanking region of the CSF1R gene. Among them, we discovered that two polymorphisms in introns were associated with a risk of asthma development by logistic analysis. The rare allele frequencies of CSF1R +20511C>T and CSF1R +22693T>C were signiWcantly higher in asthmatic patients versus normal controls, and this remained signiWcant after correcting for multiple Fig. 2 CSF1R protein expression on CD14 + monocytes and neutrophils in the peripheral blood of asthmatic subjects. a Gating for CD14 + among monocytes using an FITC-conjugated CD14 Ab. b Gating for neutrophils using side scatter and forward scatter. c, e Levels of CSF1R expression were compared between monocytes from asthmatic patients with the T or C alleles on CSF1R +22693T>C. d, f Levels of CSF1R expression were compared between neutrophils from asthmatic patients having the C allele at CSF1R +22693T>C and having the T allele at CSF1R +22693T>C comparisons. This indicates that the rare alleles, CSF1R +20511C>T and CSF1R +22693T>C, in the intron may have some genetic susceptibility eVect on the risk of asthma. Genetic variants exert their eVects via alteration of the gene product, the protein. The eVects of CSF1 are mediated by the CSF1 receptor tyrosine kinase (CSF1R) through autophosphorylation of CSF1R and the subsequent phosphorylation of downstream molecules. Triggering this phosphorylation cascade increases gene transcription and protein translation and induces cytoskeletal remodeling by several signaling pathways, leading to the survival, proliferation, and diVerentiation of target cells (Pixley and Stanley 2004) . Functional derangement of phosphorylation of CSF1R has been documented in pulmonary alveolar proteinosis (PAP). PAP is an autoimmune disorder in which autoantibodies interfere with signaling through the granulocyte-macrophage colony-stimulating factor receptor, leading to macrophage and neutrophil dysfunction (Juvet et al. 2008 ). Additionally, CSF1 is able to prime some innate immune responses by modulation of Toll-like receptors. Stimulation of monocytes and macrophages with CSF1 downregulates the expression of TLR1, TLR5, TLR2, TLR6, and TLR9 (O'Mahony et al. 2008; Sweet et al. 2002) and increases expression of CD14 (Ji et al. 2004 ). Thus, CSF1 enhances cytokine production in response to LPS, but suppresses the CpG DNA response (Sweet et al. 2002) . These data suggest that CSF1R expression may be associated with various inXammatory responses, including the innate immune response, in asthma pathogenesis. However, no association between genetic variants in the CSF1R gene or protein has been documented in asthma.
The intronic SNPs of CSF1R gene in the present study may lead to diVerential production in the quantity of CSF1R protein or to structural variants. Thus, functional validation is necessary to conWrm the genetic eVect. To validate the genetic eVect of CSF1R +20511C>T and CSF1R +22693T>C, the protein level on neutrophils and monocytes was analyzed by Xow cytometry because these cells are known to express the receptor on their surface (Buckle et al. 1990 ). To separate monocytes clearly by Xow cytometry, CD14 + cells were gated to eliminate other cells. Asthmatic patients having the rare alleles had signiWcantly increased CSF1R expression on neutrophils and CD14 + monocytes compared with those with the common +22693T>C T alleles. These data indicate that the rare allele genotype increases protein expression of CSF1R gene, leading to asthma development via diVerential regulation of neutrophils, monocytes, and other immune cells, including dendritic cells, although we did not measure CSF1R protein expression on dendritic cells. Interestingly, CSF1R expression was independent from the CSF1R +20511C>T genotype. It is well known that intronic SNPs can aVect transcript processing through alternative splicing or producing RNA secondary structure (Chen and Stephan 2003) . Because the CSF1R +22693T>C is located in the intron, we next checked the presence of alternatively spliced forms of CSF1R by RT-PCR.
No alternative splicing was found in the subjects having rare or common homozygotes. Thus, one of the explanations for the diVerential protein expression of the CSF1R gene may be diVerent mRNA production, due to a change in RNA secondary structure according to genotype (Zuker 2003) . The secondary structure containing the C allele of +22693T>C has a G of ¡127.25 kcal/mol, and the T allele has a G of ¡131.45 kcal/mol (Supplemental Fig. 1 ). These data suggest that this SNP may aVect the secondary structure of the CSF1R gene. To validate the functional eVect of the +22693 T>C on RNA processing, we measured mRNA levels using RT-PCR. We found that mRNA expression in neutrophils having the C alleles at +22693 C was signiWcantly higher than in those having the T alleles at +22693. This indicates that the diVerential RNA production may be derived from a genetic eVect of the SNP.
In summary, we genotyped human CSF1R gene polymorphisms and found that the rare allele CSF1R +22693T>C was associated with the risk of asthma via increasing CSF1R mRNA and protein expression on neutrophils and monocytes. This information on the genetic polymorphism of the CSF1R gene may be useful for improving asthma treatment and developing new strategies for controlling bronchial asthma.
